Premier Path Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Premier Path Wealth Partners's AMGN Position: Q3 2026 in Review
Premier Path Wealth Partners reduced its Amgen (AMGN) stake by 2.4% in Q3 2026, selling an estimated $59.8K and leaving 6,088 shares worth $2.57M. The position accounts for 0.3% of the portfolio, ranked #80.
Premier Path Wealth Partners first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Premier Path Wealth Partners held 6,088 shares of Amgen worth $2.57M as of Q3 2026.
- Premier Path Wealth Partners sold 150 Amgen shares in Q3 2026, an estimated $59.8K.
- Amgen made up 0.3% of Premier Path Wealth Partners's portfolio in Q3 2026, its #80 holding.
- Premier Path Wealth Partners first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
- 2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Premier Path Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.